Skip to main content
. 2018 May 2;23(5):1062. doi: 10.3390/molecules23051062

Figure 5.

Figure 5

Administration with TRYP inhibited the expression of NF-κBp65, magnification ×400. (A) Immunohistochemistry result of control group with expressing NF-κBp65 barely. (B) The expression level of NF-κBp65 increased sharply with crypts and goblet cells disappeared. (C) Immunohistochemistry result of sulfasalazine control. (DF) The expression level of NF-κBp65 with different concentrations of TRYP treatment. (G) The column heights represented the positively stained cell rates. Error bars represented means ± SEM of n = 3, ** p < 0.01 compared with colitis.